Abstract
This article examines a paradox. India has received worldwide recognition as a low-cost producer of high-quality drugs. This has contributed to accessibility of drugs abroad and reflects strong innovative capabilities developed in India. Yet at home, most Indian people do not have regular access to essential medicines. The contrast between the success of Indian industrial policy in developing the industry and the failure of Indian health policy in ensuring access to drugs demonstrates starkly the need for integration of industrial and health policies if safe universal access to essential medicines is to be achieved.
Cet article analyse un paradoxe. L'Inde est connue pour sa capacité à produire des médicaments de bonne qualité à bas prix. Cela a contribué à rendre ces produits plus accessibles aux populations de différents pays. Cependant, les populations indiennes ont des difficultés à accéder aux médicaments essentiels. Le contraste entre l'agressivité de la politiqueindustrielle et l'incapacité des services de santé à fournir un accès équitable aux médicaments montre le besoin d'intégrer ces deux dimensions si l'on veut plus d'équité en matière d'accès aux soins.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chaudhuri, S. The Gap Between Successful Innovation and Access to its Benefits: Indian Pharmaceuticals. Eur J Dev Res 19, 49–65 (2007). https://doi.org/10.1080/09578810601144293
Published:
Issue Date:
DOI: https://doi.org/10.1080/09578810601144293